Advertisement

Topics

Apatinib/Etoposide Promising in Platinum-Resistant Ovarian Cancer

06:25 EDT 15 Sep 2018 | Cancer Networks

Apatinib combined with etoposide offers promising efficacy in patients with platinum-resistant ovarian cancer.

Original Article: Apatinib/Etoposide Promising in Platinum-Resistant Ovarian Cancer

NEXT ARTICLE

More From BioPortfolio on "Apatinib/Etoposide Promising in Platinum-Resistant Ovarian Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...